1. Home
  2. ALGT vs SNDX Comparison

ALGT vs SNDX Comparison

Compare ALGT & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allegiant Travel Company

ALGT

Allegiant Travel Company

HOLD

Current Price

$97.95

Market Cap

2.0B

ML Signal

HOLD

Logo Syndax Pharmaceuticals Inc.

SNDX

Syndax Pharmaceuticals Inc.

HOLD

Current Price

$22.19

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALGT
SNDX
Founded
1997
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
ALGT
SNDX
Price
$97.95
$22.19
Analyst Decision
Hold
Strong Buy
Analyst Count
10
13
Target Price
$100.30
$80.23
AVG Volume (30 Days)
558.3K
1.1M
Earning Date
05-06-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
81.62
11.56
EPS
N/A
N/A
Revenue
$2,606,579,000.00
$172,352,000.00
Revenue This Year
$5.50
$619.64
Revenue Next Year
$8.47
$115.96
P/E Ratio
N/A
N/A
Revenue Growth
3.74
627.84
52 Week Low
$39.82
$8.59
52 Week High
$118.00
$22.73

Technical Indicators

Market Signals
Indicator
ALGT
SNDX
Relative Strength Index (RSI) 45.57 61.76
Support Level $83.67 $19.59
Resistance Level $118.00 $22.33
Average True Range (ATR) 5.79 1.02
MACD -1.73 0.13
Stochastic Oscillator 10.66 87.03

Price Performance

Historical Comparison
ALGT
SNDX

About ALGT Allegiant Travel Company

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of under-served cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in under-served cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates maximum revenue, and Sunseeker Resort.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

Share on Social Networks: